April 27, 2020 / 11:31 AM / a month ago

BRIEF-Astrazeneca Says Lokelma U.S. Label Updated To Add Dosing Guidance For Treatment Of Hyperkalemia In Patients With End-Stage Renal Disease On Hemodialysis

April 27 (Reuters) - AstraZeneca PLC:

* ASTRAZENECA - LOKELMA U.S. LABEL UPDATED TO ADD DOSING GUIDANCE FOR TREATMENT OF HYPERKALEMIA IN PATIENTS WITH END-STAGE RENAL DISEASE ON HEMODIALYSIS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below